No Oklahoma Tort Duty for Pharmacies to Fill Prescriptions Absent a Voluntary Undertaking; “Right Not to Fill” Regulation Treated as Clarifying

Case: Scholl v. Walgreens Specialty Pharmacy
Court: U.S. Court of Appeals for the Tenth Circuit
Date: August 6, 2026

1) Introduction

The plaintiffs—Eric and Jacqueline Scholl and their minor daughter J.J.S.—brought an Oklahoma negligence claim against Walgreens Specialty Pharmacy after an extended delay in obtaining Lupron Depot, a specialty medication prescribed to treat J.J.S.’s vaginal agenesis. The core factual dispute was not whether the medication was important or whether the delay was unfortunate, but whether Walgreens had a legal duty (before July 13, 2020) to fill the prescription when insurer preauthorization was in flux and Walgreens had internally closed the file.

The district court granted summary judgment for Walgreens on the threshold element of duty. On appeal, the Scholls argued (i) the district court effectively entered sua sponte summary judgment on an unraised ground, and (ii) Oklahoma statutes, regulations, and common law imposed (or Walgreens’ conduct created) a duty to fill the prescription earlier than July 13. The Tenth Circuit affirmed.

2) Summary of the Opinion

The Tenth Circuit held that the Scholls had notice and a fair opportunity to address the duty question at summary judgment, and in any event showed no prejudice. Substantively, the court made an Erie prediction that the Oklahoma Supreme Court would find no general tort duty requiring a pharmacy to fill a prescription under the circumstances presented.

The court emphasized three points: (1) Oklahoma’s Pharmacy Act and implementing regulations do not impose an express duty to fill prescriptions; (2) Oklahoma regulations affirmatively recognize pharmacists’ discretion not to fill (including a 2022 amendment stating a pharmacist “maintains the right not to fill the valid prescription,” treated as clarifying and thus retrospective); and (3) the record lacked evidence of a voluntary undertaking, promise, or contractual commitment by Walgreens to fill the prescription before July 13, 2020.

3) Analysis

3.1 Precedents Cited

  • Marshall v. City of Tulsa and Lowery v. Echostar Satellite Corp.: Used for the foundational proposition that duty is the “threshold question” in negligence and a question of law for the court; absent duty, negligence fails as a matter of law.
  • Knox v. Okla. Gas & Elec. Co.: Cited for the sources from which a legal duty may arise (statute, common law, implication/operation of law, and the parties’ relationship/situation), framing the court’s two-track inquiry: affirmative law vs. conduct-based undertaking.
  • Erie R.R. Co. v. Tompkins, Mitchell v. Roberts, Evanston Ins. Co. v. Desert State Life Mgmt., Bartch v. Barch, FDIC v. Schuchmann, and Lawson v. Spirit AeroSystems, Inc.: These supply the Erie methodology—apply state supreme court law when available, otherwise predict it, guided by caution in expanding state law absent clear guidance.
  • Pharmcare Okla., Inc. v. State Health Care Auth. and Carista v. Valuck: Treated as the most relevant Oklahoma appellate guidance on pharmacist duties. The opinion relied on these cases for the proposition that a pharmacist’s duties are “clearly defined and limited under the Pharmacy Act,” and rejected the plaintiffs’ attempt to reframe those cases as recognizing a general duty to fill.
  • Harwood v. Ardagh Grp. and Trinity Baptist Church v. Bhd. Mut. Ins. Servs., LLC: Cited for Oklahoma’s voluntary undertaking / relationship-based duty concepts. The court distinguished Harwood because Walgreens had not made comparable representations or engaged in a continuing course of conduct amounting to an undertaking to fill.
  • Polymer Fabricating, Inc. v. Emps. Workers' Comp. Ass'n (and N. Coltrane Cmty. Ass'n, Inc. v. Bd. of Cnty. Comm'rs of Okla. Cnty.): Used to justify treating the 2022 Oklahoma pharmacy regulation amendment as a “clarifying enactment” with retrospective force.
  • Procedural (sua sponte / notice / prejudice) authorities: Celotex Corp. v. Catrett, Snyder v. Beam Techs., Inc., Oldham v. O.K. Farms, Inc., Scull v. New Mexico, Johnson v. Weld County, Safeway Stores 46 Inc., v. WY Plaza LC, A.M. v. Holmes, and Interstate Med. Licensure Compact Comm'n v. Bowling. These cases guided the court’s conclusion that the duty issue was squarely joined in the briefing and, regardless, the Scholls could not identify additional evidence establishing prejudice.

3.2 Legal Reasoning

(a) No statutory/regulatory duty to fill. The court read Oklahoma’s Pharmacy Act and the Board of Pharmacy’s regulations as comprehensive but not imposing an affirmative obligation to fill a prescription—especially where preauthorization and other external requirements prevent dispensing. The court emphasized that the regulatory scheme includes discretion to refuse dispensing in certain circumstances and, critically, the later regulation explicitly stating “The pharmacist maintains the right not to fill the valid prescription.” The opinion treated that 2022 text as confirming what the prior scheme implied: no general duty to fill.

(b) The “clarifying enactment” move. A key doctrinal step is the court’s prediction that the Oklahoma Supreme Court would apply the 2022 “right not to fill” regulation retrospectively because it was characterized by the Board as a clarification. Using Polymer Fabricating, Inc. v. Emps. Workers' Comp. Ass'n, the court concluded the amendment did not create a new duty or remove a vested right; it clarified an already non-mandatory framework.

(c) Limits of conduct-based duty (voluntary undertaking). The Scholls’ theory depended on Walgreens’ alleged “promise” to fill and alleged undertaking through actions pursuing preauthorization. The court found the record did not show an agreement, promise, or indication that Walgreens would proceed with filling before July 13; at most, Walgreens investigated insurance coverage and communicated that preauthorization was required and obtainable only by the physician. That activity did not equal an undertaking “to render services” to fill the prescription irrespective of prerequisites, and the court rejected the attempt to transform “efforts to determine if filling is permissible” into a binding undertaking to fill.

(d) Procedure: not improper sua sponte summary judgment. The court held the duty question was the centerpiece of the case and was fully briefed. Even if notice were imperfect, the Scholls failed to identify any additional evidence they would have offered—especially since discovery was closed and they neither sought Rule 56(d) relief nor pointed to unconsidered evidence.

3.3 Impact

For Oklahoma pharmacy-negligence litigation (in federal court): The decision is a strong Erie-based signal that, absent a specific undertaking or special relationship beyond ordinary pharmacy processing, Oklahoma law will not recognize a freestanding tort duty requiring a pharmacy to fill a prescription on a patient’s preferred timeline, particularly where payer authorization is a gating condition.

For “voluntary undertaking” theories: The opinion draws a practical evidentiary line: communications about prerequisites (e.g., “we need prior authorization”) and internal processing are not, without more, an actionable promise to fill. Plaintiffs will likely need direct evidence of commitment—express assurance, acceptance of an out-of-pocket arrangement, confirmed order initiation, scheduled delivery, or similar reliance-inducing conduct.

For regulatory interpretation: By treating the 2022 “right not to fill” provision as clarifying, the opinion encourages defendants to argue that similar “clarifying” amendments can be deployed retrospectively to confirm there was never an underlying duty.

Note: The court did not reach causation; future cases may still litigate whether delays attributable to pharmacies (once a duty is established by undertaking or other doctrine) proximately caused injury.

4) Complex Concepts Simplified

  • Duty (tort law): A legal obligation recognized by law. If there is no duty, the negligence claim fails even if the outcome is harmful.
  • Erie prediction (“Erie guess”): When state supreme court precedent is missing, a federal court sitting in diversity predicts how that court would rule, but remains cautious about expanding state law.
  • Voluntary undertaking: A duty that arises because someone affirmatively takes on responsibility (by promise or conduct) to provide a service; liability can follow if the undertaking is performed negligently. Mere preliminary steps or conditional processing may not qualify.
  • Sua sponte summary judgment: Summary judgment on a ground not raised by a party. It is permitted if the losing party had notice and a fair chance to respond and cannot show prejudice.
  • Clarifying enactment (retroactivity): A later amendment interpreted as explaining what the law always meant, rather than changing it; courts may apply it to earlier events.

5) Conclusion

Scholl v. Walgreens Specialty Pharmacy crystallizes a restrictive view of pharmacy duty under Oklahoma law in the absence of a proven voluntary undertaking or contractual commitment. Relying on the Pharmacy Act’s limited-duty framing from Pharmcare Okla., Inc. v. State Health Care Auth. and Carista v. Valuck, and treating the 2022 “right not to fill” regulation as clarifying, the Tenth Circuit held that Walgreens owed no duty to fill the prescription before July 13, 2020. The opinion’s broader significance lies in how it channels future negligence claims toward evidence of affirmative commitment (or other recognized duty-creating relationships) rather than general appeals to professional obligation or corporate processing activity.